Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Quetiapine for treatment of alcohol dependence.

Monnelly EP, Ciraulo DA, Knapp C, LoCastro J, Sepulveda I.

J Clin Psychopharmacol. 2004 Oct;24(5):532-5.

PMID:
15349010
[PubMed - indexed for MEDLINE]
2.

Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.

Martinotti G, Andreoli S, Di Nicola M, Di Giannantonio M, Sarchiapone M, Janiri L.

Hum Psychopharmacol. 2008 Jul;23(5):417-24. doi: 10.1002/hup.944.

PMID:
18425995
[PubMed - indexed for MEDLINE]
3.

Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: a case series.

Croissant B, Klein O, Gehrlein L, Kniest A, Hermann D, Diehl A, Mann K.

Eur Psychiatry. 2006 Dec;21(8):570-3.

PMID:
17161284
[PubMed - indexed for MEDLINE]
4.

A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.

Kampman KM, Pettinati HM, Lynch KG, Whittingham T, Macfadden W, Dackis C, Tirado C, Oslin DW, Sparkman T, O'Brien CP.

J Clin Psychopharmacol. 2007 Aug;27(4):344-51.

PMID:
17632217
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders.

Brown ES, Garza M, Carmody TJ.

J Clin Psychiatry. 2008 May;69(5):701-5.

PMID:
18312058
[PubMed - indexed for MEDLINE]
6.

Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder.

Sokolski KN, Denson TF, Lee RT, Reist C.

Mil Med. 2003 Jun;168(6):486-9.

PMID:
12834142
[PubMed - indexed for MEDLINE]
7.

Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.

Sattar SP, Schultz SK, Arndt S, Soundy T, Petty F.

S D Med. 2007 Nov;60(11):437, 439-41, 443 passim.

PMID:
18196687
[PubMed - indexed for MEDLINE]
8.

A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients.

Litten RZ, Fertig JB, Falk DE, Ryan ML, Mattson ME, Collins JF, Murtaugh C, Ciraulo D, Green AI, Johnson B, Pettinati H, Swift R, Afshar M, Brunette MF, Tiouririne NA, Kampman K, Stout R; NCIG 001 Study Group.

Alcohol Clin Exp Res. 2012 Mar;36(3):406-16. doi: 10.1111/j.1530-0277.2011.01649.x. Epub 2011 Sep 26.

PMID:
21950727
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.

Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W; BOLDER Study Group.

Bipolar Disord. 2007 Jun;9(4):413-25.

PMID:
17547587
[PubMed - indexed for MEDLINE]
10.

Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety.

Byers MG, Allison KM, Wendel CS, Lee JK.

J Clin Psychopharmacol. 2010 Jun;30(3):225-9. doi: 10.1097/JCP.0b013e3181dac52f.

PMID:
20473055
[PubMed - indexed for MEDLINE]
11.

A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving.

Ray LA, Chin PF, Heydari A, Miotto K.

Psychopharmacology (Berl). 2011 Oct;217(3):341-51. doi: 10.1007/s00213-011-2287-3. Epub 2011 Apr 13.

PMID:
21487653
[PubMed - indexed for MEDLINE]
12.

Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.

Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H, Walden J, Bauer M, Grunze H.

J Clin Psychopharmacol. 2008 Oct;28(5):555-60. doi: 10.1097/JCP.0b013e318185e75f.

PMID:
18794653
[PubMed - indexed for MEDLINE]
13.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
14.

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762].

Carey PD, Vythilingum B, Seedat S, Muller JE, van Ameringen M, Stein DJ.

BMC Psychiatry. 2005 Jan 24;5:5.

PMID:
15667657
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Potential benefits of quetiapine in the treatment of substance dependence disorders.

Sattar SP, Bhatia SC, Petty F.

J Psychiatry Neurosci. 2004 Nov;29(6):452-7.

PMID:
15644986
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.

Dossenbach M, Arango-Dávila C, Silva Ibarra H, Landa E, Aguilar J, Caro O, Leadbetter J, Assunção S.

J Clin Psychiatry. 2005 Aug;66(8):1021-30.

PMID:
16086618
[PubMed - indexed for MEDLINE]
17.

Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.

Gianfrancesco F, Pesa J, Wang RH.

J Manag Care Pharm. 2005 Apr;11(3):220-30.

PMID:
15804206
[PubMed - indexed for MEDLINE]
Free Article
18.
19.

Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.

Vieta E, Mullen J, Brecher M, Paulsson B, Jones M.

Curr Med Res Opin. 2005 Jun;21(6):923-34.

PMID:
15969892
[PubMed - indexed for MEDLINE]
20.

Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.

Buckley PF.

Curr Med Res Opin. 2004 Sep;20(9):1357-63.

PMID:
15383183
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk